Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,397 | -16,690 | -11,177 | -30,696 | -118,513 |
| Depreciation Amortization | 95 | 71 | 47 | 42 | 1,934 |
| Accounts receivable | N/A | N/A | N/A | 1,096 | 436 |
| Other Working Capital | 8,641 | 2,863 | 4,124 | -4,885 | 10,275 |
| Other Operating Activity | 2,356 | 284 | 189 | 3,990 | 13,790 |
| Operating Cash Flow | $-18,305 | $-13,472 | $-6,817 | $-30,453 | $-92,078 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 26,787 | 45,836 |
| PPE Investments | N/A | N/A | N/A | -836 | -2,375 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $25,951 | $43,461 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 28,298 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 5 | 5 | 5 | N/A | 1,677 |
| Other Financing Activity | -1,303 | -14 | 0 | -685 | 36,474 |
| Financing Cash Flow | $27,000 | $-9 | $5 | $-685 | $38,151 |
| Beginning Cash Position | 22,919 | 22,919 | 22,919 | 53,683 | 64,149 |
| End Cash Position | 31,614 | 9,438 | 16,107 | 48,496 | 53,683 |
| Net Cash Flow | $8,695 | $-13,481 | $-6,812 | $-5,187 | $-10,466 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,305 | -13,472 | -6,817 | -30,453 | -92,078 |
| Capital Expenditure | N/A | N/A | N/A | -836 | -2,375 |
| Free Cash Flow | -18,305 | -13,472 | -6,817 | -31,289 | -94,453 |